Monte Rosa Therapeutics, Inc. (GLUE)
14.18
-0.04
(-0.28%)
USD |
NASDAQ |
Sep 03, 15:44
Monte Rosa Therapeutics Net Income (Annual) : -38.63M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -38.63M |
| December 31, 2024 | -72.70M |
| December 31, 2023 | -135.35M |
| December 31, 2022 | -108.50M |
| Date | Value |
|---|---|
| December 31, 2021 | -73.96M |
| December 31, 2020 | -35.88M |
| December 31, 2019 | -7.74M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Nurix Therapeutics, Inc. | -264.46M |
| Gilead Sciences, Inc. | 8.51B |
| Ironwood Pharmaceuticals, Inc. | 24.02M |
| Capricor Therapeutics, Inc. | -105.04M |
| Cue Biopharma, Inc. | -26.60M |